S. Bernichtein et al., S179D-human PRL, a pseudophosphorylated human PRL analog, is an agonist and not an antagonist, ENDOCRINOL, 142(9), 2001, pp. 3950-3963
For many years, our group has been involved in the development of human PRL
antagonists. In two recent publications, S179D-human PRL, a human PRL anal
og designed to mimic a putative S179-phosphorylated human PRL, was reported
to be a highly potent antagonist of human PRL-induced proliferation and si
gnaling in rat Nb2 cells. We prepared this analog with the aim of testing i
t in various bioassays involving the homologous, human PRL receptor. In our
hands, S179D-human PRL was able to stimulate 1) the proliferation of rat N
b2 cells and of human mammary tumor epithelial cells (T47D), 2) transcripti
onal activation of the lactogenic hormone response element-luciferase repor
ter gene, and 3) activation of the Janus kinase/signal transducer and activ
ator of transcription and MAPK pathways. Using the previously characterized
antagonist G129R-human PRL as a control, we failed to observe any evidence
for antagonism of S179D-human PRL toward any of the human PRL-induced effe
cts analyzed, including cell proliferation, transcriptional activation, and
signaling. In conclusion, our data argue that S179D-human PRL is an agonis
t displaying slightly reduced affinity and activity due to local alteration
of receptor binding site 1, and that the antagonistic properties previousl
y attributed to S179D-human PRL cannot be confirmed in any of the assays an
alyzed in this study.